The National Law Review23d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
Obtaining approvals from Health Canada and the EMA reaffirms our dedication to patient safety and the quality of therapeutic products. This level of certification makes C3i Center a Canadian ...
Canadian Manufacturing23d
C3i to manufacture cell therapy products for European market
Obtaining approvals from Health Canada and the EMA reaffirms our dedication to patient safety and the quality of therapeutic products. This level of certification makes C3i Center a Canadian ...
GEN23d
C3i Center Receives EMA Approval to Manufacture Cell Therapy Products for Europe
Obtaining approvals from Health Canada and the EMA reaffirms our dedication to patient safety and the quality of therapeutic products. This level of certification makes C3i Center a Canadian ...
Financial Post23d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
Obtaining approvals from Health Canada and the EMA reaffirms our dedication to patient safety and the quality of therapeutic products. This level of certification makes C3i Center a Canadian reference ...